Overview

Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of...

Open

$0.00

Prior close

$231.35

Today's high

$0.00

Today's low

$0.00

52 Week high

$280.80

52 Week low

$22.28

News

Zacks Investment Research • 21 hours ago • MRNA

Moderna Issues Cost Outlook Amid Revenue Uncertainty, Stock Falls

MarketBeat • 1 day ago • MRNA

Moderna Targets 2027 Cancer Therapy Launch, Raises 2026 Revenue Growth Outlook

Zacks Investment Research • 1 day ago • MRNA

MRNA Stock Up 3% Since Q3 Earnings Release: How to Play the Stock?

The Motley Fool • 1 day ago • MRNA

Why Moderna Stock Dropped on Thursday

Barrons • 1 day ago • MRNA

Moderna Needs a Post-Covid Hit. Its Cancer-Drug Spending Plan Ups the Stakes.